Sulbactam-durlobactam combination therapy for carbapenem-resistant Acinetobacter baumannii sepsis with cutaneous involvement in an infant with acute monocytic leukemia: A case report
C. Fu, Xue Tang, Xia Guo, Liang Huang, Ju Gao, Rong Hua Yang
Abstract
Carbapenem-resistant Acinetobacter baumannii (CR Ab ) causes severe infections and poses significant treatment challenges. Sulbactam-durlobactam (SUL-DUR) is a novel antibiotic, but its use in children and infants has not been reported. We reported the first case of an infant with acute leukemia successfully treated with SUL-DUR for CR Ab sepsis with cutaneous involvement.
Topics & Concepts
MedicineAcinetobacter baumanniiMonocytic leukemiaAcute monocytic leukemiaSepsisSulbactamCombination therapyLeukemiaCarbapenemMicrobiologyInternal medicineAntibioticsImipenemBiologyPseudomonas aeruginosaAntibiotic resistanceBacteriaGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyInfections and bacterial resistance